Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland

British Medical Journal

Volumn 327, Issue 7422, 2003, Pages 1019-1023

  Gibb, D M ^a   Duong, T ^a   Tookey, P A ^b   Sharland, M ^c   Tudor Williams, G ^d   Novelli, V ^e   Butler, K ^f   Riordan, A ^g   Farrelly, L ^a   Masters, J ^b   Peckham, C S ^b   Dunn, D T ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^f OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^g BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHILD; CHILD HOSPITALIZATION; CHILD PSYCHOLOGY; CHILDHOOD MORTALITY; CLINICAL STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFANT; IRELAND; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEGRO; NEWBORN; PERINATAL INFECTION; PREGNANCY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SOCIAL ASPECT; UNITED KINGDOM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HIV-1; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; IRELAND; MALE; MORTALITY; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL RATE;

EID: 0242288797     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Guidelines for the use of antiretroviral agents in HIV infected adults and adolescents (accessed 14 July 2003).
2. British HIV Association (BHIVA). Guidelines for the treatment of HIV infected adults with antiretroviral therapy (accessed 14 July 2003).
3. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998;352:1725-30.
4. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
5. Detels R, Munoz A, McFarlane G, Kingsley LA, Margolick JB, Giorgi J, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. JAMA 1998;280:1497-503.
6. Sharland M, Castelli Gattinara di Zub G, Ramos JT, Blanche S, Gibb DM on behalf of the PENTA Steering Committee. PENTA (Paediatric European Network for Treatment of AIDS) guidelines for the use of antiretroviral therapy in paediatric HIV infection. HIV Med 2002;3:215-26.
7. Working Group on Antiretroviral Therapy, Medical Management of HIV-infected Children convened by National Pediatric and Family HIV Resource Center, Health Resources and Services Administration, and National Institutes of Health. Guidelines for the use of antiretroviral agents in pediatric HIV infection. 2001 (accessed 22 Sep 2003).
8. World Health Organization. Scaling up antiretroviral therapy in resource-limited settings; guidelines for a public health approach. Geneva: World Health Organization, 2002.
9. Ades AE, Davison CF, Holland FJ, Gibb DM, Hudson CN, Nicoll A, et al. Vertically transmitted HIV infection in the British Isles. BMJ 1993;306:1296-9.
10. Tarwater PM, Mellors J, Gore ME, Margolick JB, Phair J, Detels R, et al. Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts. Am J Epidemiol 2001;154:675-81.
11. Gortmaker SL, Hughes M, Cervia J, Brady M, Johnson GM, Seage JR 3rd, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med 2001;345:1522-8.
12. De Martino M, Tovo PA, Balducci M, Galli L, Gabiano C, Rezza G, et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. JAMA 2000;284:190-7.
13. Cascade Collaboration. Determinants of survival following HIV-1 seroconversion after the introduction of HAART Lancet 2003;362:1267-74.
14. Unlinked Anonymous Surveys Steering Group. Prevalence of HIV and hepatitis infections in the United Kingdom 2001. London: Department of Health, 2002.
15. Kinghorn G. A sexual health and HIV strategy for England. BMJ 2001;323:243-4.